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Usually, mortality due to mild community-acquired pneumonias (CAP) (Pneumonia severity
index (PSI) classes IeIII) is low (<3%), but the appearance of hypoxemia significantly increases
mortality. Our aim was to determine the clinical parameters associated with risk factors of
developing hypoxemia in subjects with mild CAP (PSI IeIII) and the clinical outcomes of the
hypoxemic group.
We analyzed clinical characteristics and the outcomes of patients with mild CAP and hypox-
emia (PaO2/FiO2< 300), in a prospective, multicenter cohort study of 1195 patients.
Mild pneumonias (PSI IeIII) were found in 645 cases (53.9%), of which 217 (33.6%) presented
hypoxemia according to a PaO2/FiO2< 300. Patients with PaO2/FiO2< 300 required more ICU
admissions, mechanical ventilation, and developed septic shock than other PSI IeIII patients.
The clinical parameters associated with hypoxemia were: COPD, bilateral chest X-ray involve-
ment, and hypoalbuminemia.
We conclude that patients with COPD, those with bilateral chest X-ray involvement, or
hypoalbuminemia were significantly more likely to have hypoxemia in mild CAP. Hypoxemice Neumologı´a, Consorci Hospital General Universitari de Vale`ncia, Av./Tres Cruces, 2, 46014 Valencia,
961972128.
s (F. Sanz).
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1872 F. Sanz et al.patients with low-risk pneumonia have worse clinical outcomes, including more ICU admission,
need for mechanical ventilation and presence of septic shock than non-hypoxemic low-risk
patients.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Pneumonia, along with influenza, is the seventh leading
cause of death and the leading cause of infectious death in
the United States.1 Although mortality due to pneumonia
decreased significantly with the introduction of antibiotics
in the 1950s, since that time mortality has been stable or
increasing.2,3 Recently substantial attention has been
focused on increasing the percentage of patients safely
treated for community-acquired pneumonia as outpatients
rather than requiring initial hospitalization.4 However up to
9% of patients fail outpatient treatment and require
subsequent hospitalization for pneumonia.5 There are
limited and controversial data regarding why patients with
low risk of dying based on severity criteria still require
admission to the hospital.6e8
Usually, the outcome of mild community-acquired
pneumonias (CAP) (PSI IeIII) is very good with a mortality
rate less than 3%, but the appearance of hypoxemia at the
onset of pneumonia could worsen this initial prognosis.9,10
Hypoxemia is a marker of poor outcomes and has an impact
on public health; however, we are not aware of studies
evaluating the impact of hypoxemia in patients with mild
CAP. Moreover, PSI only consider as one of many factors,
hypoxemia as part of the severity assessment.9
Therefore, our aims were to determine the factors
related to hypoxemia in patients with mild CAP (PSI IeIII),
and the impact of hypoxemia on clinical outcomes (e.g.,
ICU admission, length of hospitalization, need for vaso-
pressors and mechanical ventilation and death) as
compared to non-hypoxemic patients.Materials and methods
Study sites/inclusion and exclusion criteria
We performed a prospective, multicenter cohort study of
patients with community-acquired pneumonia over one
year (October 2003 to October 2004) at 10 hospitals from
the Valencian community in Spain. This study was approved
by the local ethical committees and patients provided
informed consent.
Inclusion criteria include: age 18 years and a diagnosis
of community-acquired pneumonia defined by the presence
of at least two symptoms (fever, chest pain, dyspnea,
coughing, and expectoration) and the presence of a new
alveolar infiltrate on the chest radiograph. Exclusion
criteria included nosocomial pneumonias, defined as
developed within 48 h after hospital admission or 14 days
after hospital discharge; health-care associated pneumonia
(HCAP) including patients residing in long-term care facili-
ties, individuals who had recently been hospitalized or had
come in contact with the health-care environment (e.g.,therapy in a dialysis center); obstructive pneumonias,
pulmonary tuberculosis, and/or bronchiectasis.
Data abstraction
Demographic data collected includes: age, gender, smoking
history, alcoholism (consumption of over 80 g/day) and
illicit drug use. Comorbid conditions included: chronic
obstructive pulmonary disease (COPD), defined as current
or past smoking history (>20 pack years), clinical evalua-
tion, and pulmonary function testing showing airflow
obstruction (FEV1/FVC< 70) with a post-bronchodilator
change in FEV1 of less than 200 ml and 12%; chronic renal
failure, congestive heart failure, cerebrovascular disease,
diabetes mellitus, chronic liver disease (viral, toxic,
hepatic cirrhosis), and history of neoplasia. In addition, the
following factors associated with immunosuppression were
assessed: human immunodeficiency virus (HIV) infection,
hematological malignancies which involved humoral or
cellular immunity, chemotherapy treatment during the
previous four weeks, prolonged corticosteroid therapy
(over 20 mg of prednisone/day for at least three weeks),
and solid organ transplantation.
Clinical signs and symptoms abstracted during the
hospital admission included cough, purulent sputum, chest
pain, dyspnea, confusion, cyanosis, heart rate, respiratory
rate, temperature, and arterial blood pressure on hospital
admission. Radiological findings and basic biochemical data
collected at the time of admission included glucose levels,
serum albumin, blood urea nitrogen, creatinine, sodium,
potassium, aspartate aminotransferase (AST), alanine
aminotransferase (ALT), leukocyte count and arterial blood
gases (pH, PaO2, and PaCO2). Hypoalbuminemia was
defined as serum albumin level less than 3.5 g/dl.
PaO2/FiO2 calculation
Oxygen saturation (SpO2) was measured for all patients on
their arrival to the Emergency Department (ED) and arterial
blood gases (ABG) were obtained. Oxygen supplementation
was supplied with venturi masks in order to reach
a SpO2> 90%. For those patients who received oxygen
before ED admission, FiO2 was adjusted to maintain
a SpO2> 90%, and then an ABG was performed. PaO2 was
obtained from the ABG and FiO2 as recorded in ER medical
charts. Hypoxemia was defined as a PaO2/FiO2 ratio <300.
The present analysis focused on low-risk patients with
pneumonia with a PaO2/FiO2 ratio <300.
Risk adjustment
The method used to assess pneumonia severity was the
Pneumonia Severity Index (PSI). The pneumonia severity
index is a validated prediction rule for 30-day mortality in
Hypoxemia in mild pneumonias 1873patients with community-acquired pneumonia. This rule is
based on three demographic characteristics, five comorbid
illnesses, five physical examination findings, and seven
laboratory and radiographic findings from the time of
presentation. Patients are classified into five risk classes
with 30-day mortality ranging from 0.1% for class I to 27%
for class V for patients enrolled in the PORT cohort study.9
Low-risk patients were classified as Pneumonia Severity
Index (PSI) risk classes IeIII.
Diagnostic criteria
The following microbiological tests were performed in
order to determine the etiology of CAP patients: 1) two sets
of blood cultures, identifying the bacteria by standard
techniques, 2) urinary antigen test for Streptococcus
pneumoniae and Legionella pneumophila performed by
immunochromatography (Binax NOW urinary antigen test;
Binax, Portland, Maine, USA), 3) paired sera (4 to 6-week
intervals) for antibody determination of Chlamydophila
pneumoniae, Mycoplasma pneumoniae, L. pneumophila
and respiratory viruses, performed by complement fixation,
indirect immunofluorescence and Enzyme-LinkedTable 1 Demographic data, comorbidities and clinical, radiol
levels and pneumonia severity index score.
PSI IeIII
PaO2/FiO2< 300 (n
Demographics
Age> 65 79 (36.4)
Men 121 (55.8)
Comorbid conditions
Tobacco use 72 (33.2)
Alcohol abuse 29 (13.4)
Illicit drug abuse 1 (0.5)
Major comorbidities 110 (50.7)
COPD 59 (27.2)
CHF 16 (7.4)
Cerebrovascular disease 7 (3.2)
Neoplasia 1 (0.5)
Renal failure 1 (0.5)
Liver disease 1 (0.5)
Diabetes mellitus 34 (15.7)
Corticosteroids treatment 6 (2.8)
Clinical and radiological parameters
Dyspnea 135 (62.2)
Confusion 5 (2.3)
Cyanosis 13 (6)
Respiratory rate> 30 8 (4.6)
Bilateral chest x-ray involvement 29 (13.4)
Biochemical parameters
BUN> 30 mg/dl 122 (57.3)
Hypoalbuminemia 36 (16.6)
PaO2< 60 mmHg 152 (70)
PaCO2> 45 mmHg 26 (12)
pH< 7.35 3 (1.4)
FiO2> 21% 19 (8.8)
COPD: chronic obstructive pulmonary disease. CHF: chronic heart faiImmunoSorbent Assay (ELISA) 4) protected specimen brush
and bronchoalveolar lavage fluid, 103 cfu/ml and 104 cfu/
ml cutoff, respectively. According to ATS/IDSA guidelines,
and Spanish Respiratory Society guidelines, no sputum
specimens were collected in these initial low-risk pneu-
monia patients.11,12
An etiological diagnosis was established when the
bacteria was isolated from a sterile specimen (blood or
pleural fluid). The positivity of urinary antigen test for
S. pneumoniae and L. pneumophila was considered
a definitive diagnosis. The fourfold rise in IgG titers for
L. pneumophila, M. pneumoniae, C. pneumoniae (1:512)
was diagnostic of atypical bacteria infection.
Outcomes
Our primary outcome was hypoxemia. Secondary outcomes
were the need for ICU admission, endotracheal intubation
with mechanical ventilation, the presence of septic shock,
defined as a systolic blood pressure of <90 mmHg that was
unresponsive to fluid treatment or required vasopressors,
all-cause mortality during the hospital stay, and length of
hospital stay (excluding non-survivors).ogical and analytical characteristics according to PaO2/FiO2
P-value
Z 217) PaO2/FiO2> 300 (nZ 428)
103 (24.1) 0.001
268 (62.6) 0.093
179 (41.8) 0.233
58 (13.6) 0.965
3 (0.7) 0.987
134 (31.3) <0.001
52 (12.1) <0.001
13 (3) 0.015
3 (0.7) 0.026
1 (0.2) 0.630
5 (1.2) 0.394
5 (1.2) 0.394
39 (9.1) 0.014
11 (2.6) 0.884
164 (38.3) <0.001
5 (1.2) 0.279
1 (0.2) 0.002
4 (1.2) <0.001
23 (5.4) 0.001
205 (48.5) 0.036
46 (10.7) 0.041
2 (0.7) <0.001
6 (2) <0.001
2 (0.7) 0.423
8 (1.9) 0.003
lure. BUN: blood urea nitrogen.
1,195 CAP patients
PaO2/FiO2 >300
428 (66.4 )
PaO2/FiO2 <300
217 (33.6 )
PSI I-III
645 cases
(53.9 )
PSI IV-V 550
cases (46.1 )
Excluded from
the analysis
Without oxygen
supplementation
198 (91.2 )
With oxygen
supplementation
19 (8.8 )
Without oxygen
supplementation
420 (98.1 )
With oxygen
supplementation
8 (1.9 )
Figure 1 Flow diagram of patients with pneumonia accord-
ing to pneumonia severity score (PSI).
1874 F. Sanz et al.Statistical analyses
Results were expressed as numerical values (percentage) for
categorical variables and median (interquartile range [IQR])
for continuous variables. A bivariate analysis was made to
identify risk factors significantly associated with PaO2/
FiO2< 300. Continuous variables were analyzed using Stu-
dent’s t-test or the ManneWhitney U-test. Categorical vari-
ables were analyzed using the chi-square (X2) test (using
Yates’ correction when necessary) or Fisher’s test. A multi-
variable logistic regression model was derived with PaO2/
FiO2< 300 as the dependent variable, and those with vari-
ables p< 0.1 as well as those suspected of being related to
hypoxemia development variables (COPD, age> 65, bilateral
infiltrates on chest x-ray, and acute renal failure) as inde-
pendent variables. The statistical analysis wasmade using the
SPSS v.15.0 (SPSS Inc. Chicago, IL, USA) statistical software.
Results
Patient characteristics
A total of 1314 subjects with pneumonia were identified
and we excluded 119 HCAP subjects, resulting in 1195
subjects with CAP. Six hundred and forty five patients
(53.9%) were identified as being at low risk of mortality by
the PSI (IeIII) were included in the final cohort. The mean
age of the subjects was 52 years (SD 17.3) (IQR, 58e66
years), and the majority were men (nZ 389; 60.3%). Major
comorbid conditions were identified in 244 (39.7%) PSI IeIII
patients (Table 1).Table 2 Microbiological diagnosis stratified by PaO2/FiO2 levels
PSI IeIII
PaO2/FiO2< 300 (nZ 217
Streptococcus pneumoniae 40 (18.4)
Legionella pneumophila 34 (15.7)
Mycoplasma pneumoniae 12 (5.5)
Staphylococcus aureus 3 (1.4)
Gram-negative bacilli 2 (0.9)Hypoxemia (PaO2/FiO2< 300) was observed in 217
patients (33.6%) in PSI IeIII group (Fig. 1).
Risk factors for hypoxemia
The relationship between the development of hypoxemia
and demographic characteristics and comorbid conditions
is shown in Table 1. Most of the arterial blood gases were
performed without supplementary oxygen, although the
hypoxemic group received FiO2> 21% more frequently than
the non-hypoxemic group (19 cases [8.8%] versus 8[2.7%];
pZ 0.003). Patients who developed hypoxemia were more
likely older, had COPD, CHF, diabetes, and cerebrovascular
disease. In addition, hypoxemic patients were more likely
to present with dyspnea at the time of clinical admission,
tachypnea, cyanosis, and bilateral chest x-ray involve-
ment, hypoalbuminemia, and BUN more than 30 mg/dl
(9 mmol/l).
Hypoxemic patients had significantly lower PaO2 values
in arterial blood gases (p< 0.001) and hypercapnia, but
there were no statistically significant differences in pH
values. Hypoxemic COPD patients showed hypercapnia
more frequently than non-hypoxemic COPD patients (12/59
cases [20.3%] versus 1/52 [1.9%]; pZ 0.006).
An etiologic agent was found in 279 patients (43.1%).
Bacteremic patients presented more frequently with
hypoxemia compared to no-hypoxemia (15 [6.9%] versus 11
[2.6%]; pZ 0.001). The microbiological diagnosis of pneu-
monia was not associated with the development of hypox-
emia, except for patients with documented Staphylococcus
aureus infection and trend in the Streptococcus pneumo-
niae patients (Table 2).
Outcomes
Patients with hypoxemia had longer length of hospital stay
as compared to patients without hypoxemia (9.7 [SD 8.1]
versus 8.3 [SD 5.7] days; pZ 0.02). A total of 22 patients
(3.3%) developed complications of pneumonia. The most
frequent complications were the need for ICU admission for
19 patients (2.9%), septic shock in 4 patients (0.6%), and
requiring mechanical ventilation in 3 patients (0.5%).
Hypoxemic patients had significantly more ICU admissions
(17 [7.8%], versus 2, [0.5%]; pZ 0.000), septic shock (4
[1.8%] versus 0; pZ 0.005) and need for mechanical
ventilation (3 [1.4% versus 0; pZ 0.015). A total of 4
patients (0.6%) in PSI IeIII group died, and was similar in
both groups (pZ 0.5).and according to the pneumonia severity index (PSI) score.
p-value
) PaO2/FiO2> 300 (nZ 428)
55 (12.9) 0.059
52 (12.1) 0.214
27 (6.3) 0.695
0 0.015
4 (0.9) 0.987
Table 3 Multivariable analysis of risk factors of hypoxemic patients with mild pneumonia according to the pneumonia severity
index score.
PSI IeIII PaO2/FiO2< 300 Factor OR 95% CI p
COPD 3.49 (1.93e6.31) <0.001
Bilateral
x-ray-involvement
2.45 (1.08e5.52) 0.030
Hypoalbuminemia 1.86 (1.06e3.28) 0.031
Hypoxemia in mild pneumonias 1875The multivariable analysis demonstrated three risk
factors that were independently associated with hypoxemic
patients in PSI low-risk classes, which included: COPD (OR
3.49 [95% CI 1.9e6.3]), bilateral chest x-ray involvement
(OR 2.45 [95% CI 1.1e5.5]) and hypoalbuminemia (OR 1.86
[95% CI 1.1e3.3]) (Table 3).
For secondary outcomes, we observed that hypoxemic
patients with PSI IeIII did not have an increased mortality
compared to non-hypoxemic patients. Hypoxemic patients
presented more ICU admission and septic shock, and the
need of mechanical ventilation was higher in hypoxemic PSI
IeIII patients. The length of hospital stay was significantly
higher in hypoxemic mild pneumonias group compared to
the non-hypoxemic group (Table 4).
Discussion
The results of our study show that one third of patients with
CAP initially classified according to the most common
severity of illness score (PSI) as mild, present with hypox-
emic respiratory failure. In addition, our results show that
a history of COPD, bilateral pulmonary infiltrates and
hypoalbuminemia were independently associated with
hypoxemic respiratory failure. CAP patients that developed
hypoxemic respiratory failure had worse clinical outcomes,
including length of stay in the hospital, ICU admission,
developing septic shock, and the need for mechanical
ventilation.
One of the main pathophysiological complications of
patients with CAP is the development of hypoxemia,
because it reflects the severity of the lung compromise due
to the intrapulmonary shunt secondary to the alteration of
the alveolar ventilation of the affected zone. The presence
of respiratory failure is an independent risk factor for
mortality in CAP and its appearance determines the use of
special treatments including oxygen therapy, non-invasive
mechanical ventilation, admission to the ICU, and the needTable 4 Clinical outcomes in pneumonia patients with low-risk
PSI IeIII Univariate analysis
PaO2/FiO2< 300 (nZ 217),
n (%)
PaO
n (
Length of stay (days) 9.7 8.1 8.3
ICU admission 17 (7.8) 2 (
Septic shock 4 (1.8) 0
Mechanical ventilation 3 (1.4) 0
Death 2 (0.9) 2 (for mechanical ventilation.13 Roso´n, et al. examined in
a prospective study the association between the PSI score,
the pneumonia etiology and the pneumonia clinical evolu-
tion. They analyzed 533 cases of CAP on which 43.1% belong
to the low-risk class. Sixty-six percent of the patients from
the cohort were hypoxemic at the time of the diagnosis,
and 60% of the low-risk patients were hospitalized. CAP
patients with hypoxemic respiratory failure had five times
higher pneumonia mortality compared to non-hypoxemic
patients.14 Mortensen and colleagues reported in a cohort
study of 2287 patients, which evaluated the causes of death
from the Pneumonia Patients Outcomes Research Team
(PORT) study. They found that hypoxemia (defined as
oxygen saturation <90% or PaO2< 60 mmHg) was the most
frequent cause of death in CAP patients: Hypoxemia was
reported in 38% of all the deaths, and it was independently
associated with pneumonia related mortality with an
hazard risk of 1.99 (95% CI 1.32e3.00).15
Current available severity of illness scores used in
patients with CAP vary on the importance of evaluating
hypoxemia: The PSI score gives a small point score for
hypoxemia (only 10 points). On the other hand, it is well
accepted in the medical community that hypoxemia is
a strong indicator to admit patients in the hospital, inde-
pendent of the severity of the pneumonia at the time of
presentation.11
In our cohort of patients with mild CAP, hypoxemia was
associated with prior history of COPD, the presence of
bilateral alveolar infiltrates, and hypoalbuminemia. The
pneumonia severity scores lack of enough sensitivity to
detect the risk factors associated with hypoxemia. History
of COPD is not a parameter used in the commonly used
severity of illness scores (PSI or CURB-65). However, recent
data suggest that COPD is associated with worse clinical
outcomes in patients hospitalized with CAP and admitted to
the ICU.15e17 History of COPD influences the decision to
admit low-risk CAP patients to the hospital, with four timesclass of according to the pneumonia severity index score.
2/FiO2> 300 (nZ 428),
%)
OR (95% CI) p-value
 5.7 e 0.020
0.5) 18.11 (4.1e79.1) <0.001
2.98 (2.7e3.3) 0.005
3.23 (2.7e3.4) 0.015
0.5) 1.98 (0.3e14.2) 0.500
Appendix: NAC-CV Study Group
Carmen Aguar. Servicio de Neumologı´a. Hospital General
de Castello´n (Spain).
A´ngela Cervera. Servicio de Neumologı´a. Hospital Uni-
versitari Dr. Peset de Valencia.
Miguel Angel Ciscar. Hospital de Denia, Alacant (Spain).
Carmen Ferrando. Servicio de Neumologı´a. Hospital V.
dels Lliris de Alcoi, Alacant (Spain).
Jose´ Antonio Pe´rez. Hospital Arnau de Vilanova de
Valencia (Spain).
Eva Martı´nez. Servicio de Neumologı´a. Hospital de
Sagunto, Valencia (Spain).
Luı´s Miravet. Servicio de Neumologı´a. Hospital
de Vinaro´s, Castello´n (Spain).
Cristina Senent. Servicio de Neumologı´a. Hospital Sant
Joan de Alacant (Spain).
1876 F. Sanz et al.higher likelihood for admission independent of the severity
of illness.8 Other proposed scales evaluating the severity of
illness of pneumonia patients have described bilateral
infiltrates on radiographic evaluation of the chest as
a factor associated with worse prognosis independent of
the poor pneumonia outcome.18 In addition, the delay in
the resolution of pneumonia was directly associated with
multilobar alveolar infiltrates.19 Furthermore, hypo-
albuminemia at the time of clinical presentation with
pneumonia was strongly associated with hypoxemia in the
multivariable analysis. The development of hypo-
albuminemia in CAP patients is associated also with higher
severity of illness, time to recovery with pneumonia,
hospital costs and mortality.20e22 Hypoalbuminemia is an
indicator of the patients’ nutritional status, but also has
been implicated as a marker of decreased hepatic synthesis
of albumin at expenses of acute phase protein production
and pro-inflammatory cytokines, which are also determined
the host inflammatory response.23 In spite of the associa-
tion between albumin plasma levels and hypoxemia in low-
risk classes of pneumonia, examining albumin results is not
useful way to predict hypoxemia.
The pneumonia severity score is an excellent tool to
assess mortality in patients with CAP, and have been
extensively evaluated to decide the need of hospital
admission or the need for outpatient treatment in this
group of patients. In fact, PSI carries a negative predictive
value as high as 98%, with high sensitivity to predict
mortality at 30 days.14,24,25 However, this scale does not
include or even exclude certain comorbidities (e.g. COPD)
or social factors that may impact the need for hospital
admission even in the low-risk class group. These char-
acteristics may affect the pneumonia progress despite the
low-risk classification.8,26 Despite the PSI score accounting
for hypoxemia, it is not considered an important factor
and lacks sensitivity. These findings have important
considerations and repercussions, due to the fact that
hypoxemia was associated with longer hospital stay,
higher rates of ICU admission, septic shock, and need for
mechanical ventilation in hypoxemic mild pneumonias
(PSI IeIII).
Our study has several limitations including: 1) The
diagnosis of COPD was based in GOLD definition, and its
presence was evaluated as a dichotomic variable and
therefore a severity stratification analysis was not per-
formed; 2) Only a few patients developed septic shock and
needed mechanical ventilation, so we are unable to fully
examine the impact of these conditions; and 3) The need
for ICU admission, is a variable definition that depends of
the bed availability in each participating hospital.27
In conclusion, our research suggests that hypoxemia
should be considered as an important parameter in
pneumonia severity assessment irrespective of the initial
severity classification by PSI. In addition, our study
demonstrates that patients with mild pneumonia
frequently have hypoxia, and that this is associated with
poor clinical outcomes.Conflict of interest
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